PFE

U.S. stock futures fell Wednesday, one day after the Dow and S&P 500 logged four-session winning streaks and the Nasdaq saw back-to-back gains.

The CDC and FDA made the decision without consulting their committees of independent vaccine experts.

“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.

Moderna also asked the FDA to authorize its vaccine for children 6- to 11-years-old, the company announced Wednesday.

AstraZeneca has taken a roughly £25 million ($33 million) stake in U.K. health start-up Huma, according to a person familiar with the matter.

These are the stocks posting the largest moves in midday trading.

U.S. stock futures bounced Tuesday after the Dow began the week by breaking a five-session winning streak.

Pfizer expects to start supplying the antiviral pills, Paxlovid, to UNICEF beginning next month and will continue to do so through the end of the year.

Officials say the new BA.2 Covid variant is about 50% to 60% more transmissible than omicron, but it does not appear to be more severe.

These are the stocks posting the largest moves in midday trading.

U.S. stock futures dropped Friday, but the S&P 500 remained on track for its best week since November 2020.

These are the stocks posting the largest moves before the bell.

Moderna CEO Stephane Bancel has sold more than 2.8 million shares since January 2020 at a total value of more than $408 million.

The S&P 500 and Nasdaq are looking for back-to-back positive sessions for the first time since late February.

The Fed is expected to raise interest rates for the first time since December 2018, while Russian and Ukrainian officials suggest some progress on peace talks.

These are the stocks posting the largest moves before the bell.

The White House is urging Congress to pass $22.5 billion in Covid spending, warning the U.S. is running out of money to fight the virus.

Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.

“China has a population that’s very vulnerable to this new variant,” the former FDA commissioner said Monday.

Two years after the World Health Organization declared the coronavirus a pandemic, public health experts warn not to become complacent.